Fate Therapeutics FATE
NASDAQ FATE
$2.37 -0.01 (-0.42%)
At close: Sep 30, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Other Operating Expenses (2023 - 2024)

Updated

Fate Therapeutics' Other Operating Expenses was $14.74 million in Q4 2024.

Analysis

Fate Therapeutics (FATE) Other Operating Expenses (2023 - 2024) Analysis & Trends

  • In earlier years, Other Operating Expenses was $2 million in FY2023.
  • The Q4 2024 figure marks the lowest quarterly Other Operating Expenses since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Fate Therapeutics 276.57 Mn 276.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 14.74 Mn
Mar 31, 2023 2.00 Mn
API Access

Fate Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=FATE&period=max&api_key=YOUR_API_KEY